StockNews.com Initiates Coverage on United-Guardian (NASDAQ:UG)

Posted by on Apr 26th, 2023

StockNews.com initiated coverage on shares of United-Guardian (NASDAQ:UG – Get Rating) in a report released on Wednesday. The brokerage set a “buy” rating on the stock.

United-Guardian Stock Performance

Shares of UG opened at $10.02 on Wednesday. The stock has a 50 day moving average price of $10.14 and a two-hundred day moving average price of $11.20. The firm has a market capitalization of $46.03 million, a P/E ratio of 17.89 and a beta of 0.47. United-Guardian has a 52 week low of $8.60 and a 52 week high of $25.10.

Institutional Investors Weigh In On United-Guardian

Institutional investors have recently made changes to their positions in the stock. UBS Group AG raised its position in shares of United-Guardian by 7.3% in the first quarter. UBS Group AG now owns 17,657 shares of the company’s stock worth $401,000 after buying an additional 1,207 shares in the last quarter. Rockefeller Capital Management L.P. lifted its stake in United-Guardian by 29.6% during the third quarter. Rockefeller Capital Management L.P. now owns 7,001 shares of the company’s stock worth $79,000 after purchasing an additional 1,600 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in United-Guardian by 1.6% during the first quarter. Dimensional Fund Advisors LP now owns 107,356 shares of the company’s stock worth $2,420,000 after purchasing an additional 1,694 shares during the last quarter. Renaissance Technologies LLC lifted its stake in United-Guardian by 0.9% during the second quarter. Renaissance Technologies LLC now owns 226,763 shares of the company’s stock worth $3,399,000 after purchasing an additional 2,100 shares during the last quarter. Finally, Neuberger Berman Group LLC lifted its stake in United-Guardian by 66.6% during the first quarter. Neuberger Berman Group LLC now owns 93,340 shares of the company’s stock worth $2,123,000 after purchasing an additional 37,300 shares during the last quarter. Hedge funds and other institutional investors own 24.40% of the company’s stock.

About United-Guardian

(Get Rating)

United-Guardian, Inc engages in the development and manufacture of pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. The firm also conducts research and product development related to the development of new and unique cosmetic and personal care products. The company was founded by Alfred R.

Featured Articles

Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.